4 Clinical Trials Found
Drug: JAB-21822 Monotherapy
Indication: NSCLC, PDAC, CRC, Other advanced solid tumors
Region: US, Europe
Drug: JAB-3312 in combination with AMG-510
Indication: NSCLC
Region: US, Europe
Drug: JAB-2485 Monotherapy
Indication: TNBC, SCLC, ER+Breast Cancer, Other advanced solid tumors
Region: China, US